• Latest Posts

Baxter’s spinoff Baxalta is building up its Oncology portfolio

Teva took the first step to get the approval of its new leukemia treatment

Theravectys: an Orphan Drug Designation for Its Lentiviral Vector-Based Therapeutic Vaccine

One Billion Strategic Oncology Alliance for the Second Largest Antibody Technology Platform

Onxeo confirms receipt of the $25M milestone payment from its US partner Spectrum